FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Methylprednisolone Acetate Injection
Status: Currently in Shortage
»Date first posted: 12/15/2021
»Therapeutic Categories: Rheumatology

Expand all

Amneal Pharmaceutical (New 12/15/2021)

Company Contact Information:
866-525-7270

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40mg/mL, 1 single-dose vial (NDC 70121-1573-01) Unavailable Increase in demand
40 mg/mL, 25 single-dose vials (NDC 70121-1573-05) Unavailable Increase in demand
80 mg/mL, 1 single-dose vials (NDC 70121-1574-01) Unavailable Increase in demand
80 mg/mL, 25 single-dose vials (NDC 70121-1574-05) Unavailable Increase in demand

Northstar (New 12/15/2021)

Company Contact Information:
972-446-4800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40mg/ml, 1ml/1 vial X 25 (NDC 16714-088-25) Available; Product on allocation Other
40mg/ml, 1ml/1 vial (NDC 16714-088-01) Available; Product on allocation Other
200mg/5ml (40mg/ml) (NDC 16714-089-01) Out of Stock Other
80mg/ml, 1ml/1 vial X 25 (NDC 16714-472-25) Available; Product on allocation Other
80mg/ml, 1ml/1 vial (NDC 16714-472-01) Available; Product on allocation Other
400mg/5ml (80mg/ml), 5ml/1 vial (NDC 16714-473-01) Available; Product on allocation Other
400mg/10ml (40mg/ml) (NDC 16714-090-01) Available; Product on allocation Other

Pfizer Pharmaceuticals (Revised 01/21/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/mL; Multidose Vial (NDC 0009-0274-01) Next Delivery: April 2023; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing delay Other
40 mg/mL; Multidose Vial (NDC 0009-0280-02) Next Delivery: April 2023; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing delay Other
40 mg/mL; Multidose Vial (NDC 0009-0280-03) Next Delivery: May 2022; Estimated Recovery: June 2023 Shortage per Manufacturer: Manufacturing delay Other
40 mg/mL; Multidose Vial (NDC 0009-0280-51) Next Delivery: April 2023; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing delay Other
40 mg/mL; Multidose Vial (NDC 0009-0280-52) Next Delivery: April 2023; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing delay Other
80 mg/mL; Multidose Vial (NDC 0009-0306-02) Next Delivery: May 2022; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing delay Other
80 mg/mL; Multidose Vial (NDC 0009-0306-12) Next Delivery: May 2022; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing delay Other
40 mg/mL; Single-dose Vial (NDC 0009-3073-01) Next Delivery: April 2023; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing delay Other
40 mg/mL; Single-dose Vial (NDC 0009-3073-03) Next Delivery: May 2022; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing delay Other
40 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3073-22) Next Delivery: April 2023; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing delay Other
80 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3073-23) Next Delivery: April 2023; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing delay Other
80 mg/mL; Single-dose Vial (NDC 0009-3475-01) Next Delivery: April 2023; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing delay Other
80 mg/mL; Single-dose Vial (NDC 0009-3475-03) Next Delivery: May 2022; Estimated Recovery: June 2023 Shortage per Manufacturer: Manufacturing delay Other
80 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3475-22) Next Delivery: April 2023; Estimated Recovery: June 2023 Shortage per Manufacturer: Manufacturing delay Other
80 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3475-23) Next Delivery and Estimated Recovery:February 2023 Shortage per Manufacturer: Manufacturing delay Other

Teva Pharmaceuticals (Reverified 01/18/2022)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
400 mg/10 mL (40 mg/mL) 10 mL Multiple-Dose Vial (NDC 0703-0045-01) Backordered; Estimated duration TBD Other
400 mg/5 mL (80 mg/mL) 5 mL Multiple-Dose Vial (NDC 0703-0063-01) Backordered; Estimated duration TBD Other
200 mg/5 mL (40 mg/mL) 5 mL Multiple-Dose Vial (NDC 0703-0043-01) Backordered; Estimated duration TBD Other
40 mg/mL 1 mL Single-Dose Vial (NDC 0703-0031-01) Backordered; Estimated duration TBD Other
80 mg/mL 1 mL Single-Dose Vial (NDC 0703-0051-01) Backordered; Estimated duration TBD Other
40 mg/mL 25 x 1 mL Single-Dose Vial (NDC 0703-0031-04 40) Backordered; Estimated duration TBD Other
80 mg/mL 25 x 1 mL Single-Dose Vial (NDC 0703-0051-04) Backordered; Estimated duration TBD Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English